Discover open access scientific publications

Search, annotate, share and cite publications

Publications by M. Lion

PGI18 Cost-Effectiveness of Boceprevir in Combination With Pegylated Interferon Alfa and Ribavirin for the Treatment of Genotype 1 Chronic Hepatitis C: Submission to the National Institute for Health and Clinical Excellence (NICE)

Value in Health

English

Related publications

PIN50 the Clinical Efficacy and Cost-Effectiveness of Boceprevir in Combination With Pegylated Interferon- Alfa and Ribavirin for the Treatment of Genotype 1 Chronic Hepatitis C Patients: A Within Trial Analysis From the Perspective of the Scottish National Health Service (NHS)

English

Pegylated Interferon and Ribavirin Combination Therapy for Chronic Hepatitis C Associated With Thyroid Dysfunction

Acta Hepatologica Japonica

Hepatology

2013

English

Safety and Efficacy of Pegylated Interferon Alpha-2a and Ribavirin Combination in Treatment of Egyptian Patients With Chronic Hepatitis C Genotype-4

IOSR Journal of Pharmacy (IOSRPHR)

2014

English

The Effect of Pegylated Interferon-Alpha2b and Ribavirin Combination Therapy for Chronic Hepatitis C Infection in Elderly Patients

English

PGI18 Treatment of Chronic Hepatitis C Patients With Peginterferon Alfa-2a or Peginterferon Alfa-2b: A Cost-Effectiveness Analysis for the Portuguese NHS Setting

English

Cost Effectiveness of Interferon or Peginterferon With Ribavirin for Histologically Mild Chronic Hepatitis C

Gut

Gastroenterology

2006

English

Combination Therapy With Pegylated Interferon Plus Ribavirin in the Treatment of Hepatitis C Virus-Related Thrombocytopenia

Current Therapeutic Research

Pharmacology

2005

English

Sudden-Onset Sarcoidosis With Severe Dyspnea Developing During Pegylated Interferon and Ribavirin Combination Therapy for Chronic Hepatitis C

Turkish Journal of Gastroenterology

Gastroenterology

2017

English

Different Values in Cost-Effectiveness Research: Institute for Clinical and Economic Review (ICER) VS. The National Institute for Care Excellence (NICE)

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by M. Lion

PGI18 Cost-Effectiveness of Boceprevir in Combination With Pegylated Interferon Alfa and Ribavirin for the Treatment of Genotype 1 Chronic Hepatitis C: Submission to the National Institute for Health and Clinical Excellence (NICE)

Related publications

PIN50 the Clinical Efficacy and Cost-Effectiveness of Boceprevir in Combination With Pegylated Interferon- Alfa and Ribavirin for the Treatment of Genotype 1 Chronic Hepatitis C Patients: A Within Trial Analysis From the Perspective of the Scottish National Health Service (NHS)

Pegylated Interferon and Ribavirin Combination Therapy for Chronic Hepatitis C Associated With Thyroid Dysfunction

Safety and Efficacy of Pegylated Interferon Alpha-2a and Ribavirin Combination in Treatment of Egyptian Patients With Chronic Hepatitis C Genotype-4

The Effect of Pegylated Interferon-Alpha2b and Ribavirin Combination Therapy for Chronic Hepatitis C Infection in Elderly Patients

PGI18 Treatment of Chronic Hepatitis C Patients With Peginterferon Alfa-2a or Peginterferon Alfa-2b: A Cost-Effectiveness Analysis for the Portuguese NHS Setting

Cost Effectiveness of Interferon or Peginterferon With Ribavirin for Histologically Mild Chronic Hepatitis C

Combination Therapy With Pegylated Interferon Plus Ribavirin in the Treatment of Hepatitis C Virus-Related Thrombocytopenia

Sudden-Onset Sarcoidosis With Severe Dyspnea Developing During Pegylated Interferon and Ribavirin Combination Therapy for Chronic Hepatitis C

Different Values in Cost-Effectiveness Research: Institute for Clinical and Economic Review (ICER) VS. The National Institute for Care Excellence (NICE)